Licenses CSD500 to RFSU AB in the Nordic Region

RNS Number : 9135V

Futura Medical PLC

19 December 2013

 

For immediate release

19 December 2013

 

 

Futura Medical PLC

("Futura" or the "Company")

Licenses CSD500 to RFSU AB in the Nordic Region

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has signed an exclusive licensing agreement with Sweden's RFSU AB for the marketing and distribution of CSD500, Futura's novel condom, in Sweden, Norway, Finland and Denmark.

This agreement is in line with Futura's strategy of licensing CSD500 to condom distributors that hold leading positions in their regions. RFSU AB is the market leader in the four Nordic countries included in this agreement.

Regulatory authorisation in all of the countries included in this agreement is provided by CSD500's CE mark, which was awarded earlier this year.

Under the terms of the agreement, RFSU AB will hold the rights to manufacture, market and distribute CSD500 in Sweden, Norway, Finland and Denmark.

The financial details of the agreement are not being disclosed although Futura will receive an upfront payment and royalties on all product sales along with certain minimum performance guarantees.

Katarina Knutz, Managing Director of RFSU AB, commented: "Our objective is to promote innovation in condom design to provide choice to our customers. CSD500 is a highly attractive addition to our product portfolio as the uniqueness of its design brings the potential to encourage the wider use of condoms."

James Barder, Futura's Chief Executive, commented: "We are delighted to sign this exclusive agreement with RFSU AB for the marketing of CSD500 in Sweden, Norway, Finland and Denmark. RFSU AB has leading market positions in these four countries, all of which use the CE mark for regulatory authorisation. We look forward to RFSU AB's launch of CSD500 in the Nordic Region during 2014."

For further information:

Futura Medical plc	+ 44 (0) 1483 685 670
James Barder, Chief Executive
Mail to: [e-mail]	www.futuramedical.com
Cenkos Securities plc	+ 44 (0) 20 7397 8927
Bobbie Hilliam
Buchanan	+ 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles

Notes to editors:

About Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare.  The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com 

 

END

 

 

MSCQVLFFXLFZFBQ